WITHZETA
LIVE

Serial Number

99603537

Owner

Lantern Pharma Inc.

Attorney

Nigamnarayan Acharya

First Use Date

Jan 20, 2026

Filing Date

Jan 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

WITHZETA Trademark

Serial Number: 99603537

WITHZETA is a trademark filed by Lantern Pharma Inc. on January 20, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Lantern Pharma Inc. (11 trademarks)

Dallas, TX 75201

Entity Type: 03

Trademark Details

Filing Date

January 20, 2026

Registration Date

Not Registered

First Use Anywhere

January 20, 2026

First Use in Commerce

January 20, 2026

Goods & Services

Providing temporary use of a non-downloadable artificial intelligence software platform featuring software for {specify the function of the software} in the fields of scientific and biomedical research; providing an online software-as-a-service (SaaS) platform featuring artificial intelligence and machine-learning software for analyzing biological, genomic, proteomic, clinical, and pharmacological data; scientific research services using artificial intelligence in the field of oncology and rare diseases; providing temporary use of a non-downloadable artificial intelligence software platform featuring software for computational models and simulations for identifying, evaluating, and prioritizing therapeutic targets, drug candidates, and combination therapies in the field of oncology; Providing on-line non downloadable software using artificial intelligence (AI) for hypothesis generation, in silico experimentation, and data-driven scientific research in the fields of {specify}; providing an online software-as-a-service (SaaS) platform featuring softwarefor designing, modeling, and optimizing clinical trial concepts and research protocols for investigational medical therapies; providing an online software-as-a-service (SaaS) platform featuring software for predictive analytics, biomarker discovery, drug response modeling, and validation of scientific hypotheses in the fields of oncology; providing scientific data analysis, visualization, and interpretation services using artificial intelligence in the field of oncology;providing an online software-as-a-service (SaaS) platform featuring software for accelerating biomedical research and development of therapeutic drugs through computational model simulations; Providing medical and scientific research information in the field of oncology and rare diseases; providing information and analysis relating to biomedical research and drug discovery, not for the purpose of diagnosis or treatment.

Downloadable computer software for providing computational models and simulations for identifying, evaluating, and prioritizing therapeutic targets, drug candidates, and combination therapies; downloadable artificial intelligence software platform featuring software for hypothesis generation, in silico experimentation, and data-driven scientific discovery in the field of oncology; downloadable computer software for designing, modeling, and optimizing clinical trial concepts and research protocols for research of medical therapies; downloadable computer software for predictive analytics, biomarker discovery, drug response modeling, and validation of scientific hypotheses in the field of oncology

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 18, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 26, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 26, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 26, 2026 CNRT
ASSIGNED TO EXAMINER
May 17, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 20, 2026 MAFR
NEW APPLICATION ENTERED
Jan 20, 2026 NWAP